BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20669025)

  • 21. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation and development of Lewy pathology: a critical update.
    Jellinger KA
    J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
    Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
    Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease.
    Buciuc M; Whitwell JL; Boeve BF; Ferman TJ; Graff-Radford J; Savica R; Kantarci K; Fields JA; Knopman DS; Petersen RC; Parisi JE; Murray ME; Dickson DW; Josephs KA
    J Neurol; 2020 May; 267(5):1444-1453. PubMed ID: 32006160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons.
    Tsuchida T; Mano T; Koshi-Mano K; Bannai T; Matsubara T; Yamashita S; Ushijima T; Nagata K; Murayama S; Toda T; Tsuji S; Iwata A
    Brain Res; 2018 Oct; 1697():59-66. PubMed ID: 29909202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports.
    Adams JW; Alvarez VE; Mez J; Huber BR; Tripodis Y; Xia W; Meng G; Kubilus CA; Cormier K; Kiernan PT; Daneshvar DH; Chua AS; Svirsky S; Nicks R; Abdolmohammadi B; Evers L; Solomon TM; Cherry JD; Aytan N; Mahar I; Devine S; Auerbach S; Alosco ML; Nowinski CJ; Kowall NW; Goldstein LE; Dwyer B; Katz DI; Cantu RC; Stern RA; Au R; McKee AC; Stein TD
    J Neuropathol Exp Neurol; 2018 Sep; 77(9):757-768. PubMed ID: 30053297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort.
    Samudra N; Fischer DL; Lenio S; Lario Lago A; Ljubenkov PA; Rojas JC; Seeley WW; Spina S; Staffaroni AM; Tablante J; Wekselman F; Lamoureux J; Concha-Marambio L; Grinberg LT; Boxer AL; VandeVrede L
    Alzheimers Dement; 2024 May; 20(5):3334-3341. PubMed ID: 38539061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.
    Ito S; Takao M; Hatsuta H; Kanemaru K; Arai T; Saito Y; Fukayama M; Murayama S
    Int J Clin Exp Pathol; 2014; 7(4):1714-23. PubMed ID: 24817969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
    Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
    J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
    Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
    Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuft-shaped astrocytes in Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
    Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
    Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder.
    Dugger BN; Murray ME; Boeve BF; Parisi JE; Benarroch EE; Ferman TJ; Dickson DW
    Neuropathol Appl Neurobiol; 2012 Apr; 38(2):142-52. PubMed ID: 21696423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Zaccai J; Brayne C; McKeith I; Matthews F; Ince PG;
    Neurology; 2008 Mar; 70(13):1042-8. PubMed ID: 18362284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
    Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
    J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.